Risk of Severe Infection among Rheumatoid Arthritis Patients on Biological DMARDs: A Population-Based Cohort Study

Biological disease-modifying anti-rheumatic drugs (bDMARDs) are widely used for the management of rheumatoid arthritis, although their benefits are counterweight by an increased risk of infections. In the present study, we used administrative data to compare the risk of severe infections among diffe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bellan, Mattia, Scotti, Lorenza, Ferrante, Daniela, Calzaducca, Elisa, Manfredi, Giulia Francesca, Sainaghi, Pier Paolo, Barone-Adesi, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181346/
https://www.ncbi.nlm.nih.gov/pubmed/35683344
http://dx.doi.org/10.3390/jcm11112955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181346/
https://www.ncbi.nlm.nih.gov/pubmed/35683344
http://dx.doi.org/10.3390/jcm11112955

Ejemplares similares